Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
BMJ Open Gastroenterology|February 1, 2022
Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort studyShaji Sebastian, Kamal V Patel, Jonathan P Segal, et al.Alimentary Pharmacology & Therapeutics|October 5, 2022
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort studyAamir Saifuddin, Alexandra J Kent, Shameer J Mehta, et al.Scandinavian Journal of Gastroenterology|March 8, 2018
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitisAxel Dignass, Ayesha Akbar, Daniel C Baumgart, et al.BMJ Open Gastroenterology|February 10, 2023
BSG 2024 IBD guidelines protocol (standard operating procedures)Ana-Maria Darie, Vasiliki Sinopoulou, Verma Ajay, et al.Journal of Crohn'S & Colitis|December 2, 2023
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResourceChristina Kapizioni, Rofaida Desoki, Danielle Lam, et al.Journal of Crohn'S & Colitis|May 10, 2026
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's diseaseNurulamin M Noor, Haiyan Zheng, Zhi Cao, et al.British Journal of Cancer|May 19, 2020
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?Vincent Ting Fung Cheung, Tarun Gupta, Anna Olsson-Brown, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 6, 2018
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine studyMarco Vincenzo Lenti, Scott Levison, Elena Eliadou, et al.The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.Pageof 8